PGC-1β inhibitors belong to a class of chemical compounds designed to target and modulate the activity of the Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-Beta (PGC-1β). PGC-1β is a transcriptional coactivator, a protein that plays a crucial role in regulating various metabolic processes within cells. It is primarily involved in the control of mitochondrial biogenesis, energy homeostasis, and the adaptation of cells to changing energy demands. PGC-1β achieves these functions by interacting with nuclear receptors and other transcription factors to stimulate the expression of genes involved in mitochondrial function, fatty acid oxidation, and oxidative phosphorylation.
PGC-1β inhibitors are synthetic or natural compounds that disrupt or attenuate the activity of PGC-1β. These inhibitors can act through various mechanisms, such as directly binding to PGC-1β, interfering with its interaction with transcription factors, or inhibiting its downstream signaling pathways. By inhibiting PGC-1β, these compounds have the ability to alter cellular metabolism and energy utilization. Researchers have been exploring PGC-1β inhibitors to gain a better understanding of the molecular mechanisms underlying metabolic regulation and to investigate their involvement in various research areas.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol may modulate sirtuin activity, which is known to influence PGC-1β expression. | ||||||
Bisphenol A | 80-05-7 | sc-391751 sc-391751A | 100 mg 10 g | $300.00 $490.00 | 5 | |
Bisphenol A is an endocrine disruptor that could potentially alter PGC-1β expression by disrupting normal hormone signaling. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
As a PPARγ agonist, rosiglitazone may affect PGC-1β activity by altering PPARγ-dependent transcription. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin affects various signaling pathways and might modulate PGC-1β expression indirectly. | ||||||
WY 14643 | 50892-23-4 | sc-203314 | 50 mg | $136.00 | 7 | |
This PPARα agonist might downregulate PGC-1β expression through PPARα-mediated signaling pathways. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Pioglitazone, another PPARγ agonist, could influence PGC-1β expression by affecting PPARγ activity. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
As a PPARα activator, fenofibrate may modulate the expression of PGC-1β through PPARα's role in lipid metabolism. | ||||||
2,4-Dinitrophenol, wetted | 51-28-5 | sc-238345 | 250 mg | $59.00 | 2 | |
This compound uncouples oxidative phosphorylation, potentially affecting PGC-1β expression by altering mitochondrial function. | ||||||
GW 9662 | 22978-25-2 | sc-202641 | 5 mg | $70.00 | 30 | |
GW9662 is a PPARγ antagonist that may downregulate PGC-1β by inhibiting PPARγ-dependent gene expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
This MEK inhibitor could affect PGC-1β expression by altering MAPK/ERK pathway signaling. | ||||||